Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Cldn7em1flox/Cya
Common Name:
Cldn7-flox
Product ID:
S-CKO-17624
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cldn7-flox
Strain ID
CKOCMP-53624-Cldn7-B6J-VB
Gene Name
Cldn7
Product ID
S-CKO-17624
Gene Alias
--
Background
C57BL/6JCya
NCBI ID
53624
Modification
Conditional knockout
Chromosome
11
Phenotype
MGI:1859285
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Cldn7em1flox/Cya mice (Catalog S-CKO-17624) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000108597
NCBI RefSeq
NM_001193619
Target Region
Exon 3~5
Size of Effective Region
~1.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Cldn7, also known as claudin 7, is a major component of tight junctions (TJs) [2,4,5,6,7]. TJs play a crucial role in maintaining cell-cell adhesion, and Cldn7 is involved in various biological processes related to cell-cell interactions. It is associated with pathways like the regulation of cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) [1,3,5,6,7].

In colorectal cancer, in vitro and in vivo assays using p53 wild-type CRC cells showed that Cldn7, which is regulated by p53, inhibits cell proliferation [1]. High Cldn7 expression was negatively correlated with tumor size, invasion depth, lymphatic metastasis, and AJCC III/IV stage, and positively associated with favorable prognosis [1].

In breast cancer, database and clinical sample validation indicated that Cldn7 was significantly overexpressed and its overexpression was correlated with poor DFS [3]. TIMER2.0 analysis showed its overexpression was negatively associated with the activation of B-cells, CD4+ T-cells, and CD8+ T-cells, but positively with M0 macrophages [3].

In gastric cancer, Cldn7 was overexpressed, and it promoted cancer cell proliferation, invasion, and EMT [6].

In clear cell renal cell carcinoma (ccRCC), downregulation of Cldn7 due to promoter hypermethylation was associated with cancer progression and poor prognosis, and overexpression of Cldn7 induced cell apoptosis, suppressed proliferation, migration, and invasion of ccRCC cells in vitro and in vivo [7].

In murine breast cancer models, Cldn7 knockdown in organoids induced smooth muscle actin (SMA)-related genes and a mesenchymal phenotype, and Cldn7 was shown to suppress breast cancer invasion and metastasis through negative regulation of SMA-related and mesenchymal gene expression [8].

In conclusion, Cldn7 is a key component of tight junctions that significantly impacts the development and progression of multiple cancers, including colorectal, breast, gastric, and clear cell renal cell carcinomas, as well as breast cancer metastasis. Studies using in vitro and in vivo models, including gene-related functional studies in cancer cells, have revealed its role in regulating cell proliferation, invasion, apoptosis, and EMT, highlighting its potential as a biomarker and therapeutic target in these disease areas.

References:
1. Hou, Yichao, Hou, Lidan, Liang, Yu, Fang, Jingyuan, Meng, Xiangjun. 2020. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance. In Neoplasia (New York, N.Y.), 22, 590-603. doi:10.1016/j.neo.2020.09.001. https://pubmed.ncbi.nlm.nih.gov/32992138/
2. Yang, Hui-Li, Lai, Zhen-Zhen, Shi, Jia-Wei, Li, Da-Jin, Li, Ming-Qing. 2022. A defective lysophosphatidic acid-autophagy axis increases miscarriage risk by restricting decidual macrophage residence. In Autophagy, 18, 2459-2480. doi:10.1080/15548627.2022.2039000. https://pubmed.ncbi.nlm.nih.gov/35220880/
3. Fan, Xiaojie, Qi, Aifeng, Zhang, Meng, Han, Dandan, Liu, Yueping. 2024. Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer. In Diagnostic pathology, 19, 113. doi:10.1186/s13000-024-01513-1. https://pubmed.ncbi.nlm.nih.gov/39175074/
4. Marincola Smith, Paula, Choksi, Yash A, Markham, Nicholas O, Means, Anna L, Beauchamp, R Daniel. 2021. Colon epithelial cell TGFβ signaling modulates the expression of tight junction proteins and barrier function in mice. In American journal of physiology. Gastrointestinal and liver physiology, 320, G936-G957. doi:10.1152/ajpgi.00053.2021. https://pubmed.ncbi.nlm.nih.gov/33759564/
5. Wang, Wentao, Zhou, Yi, Li, Wei, Quan, Chengshi, Li, Yanru. 2024. Claudins and hepatocellular carcinoma. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 171, 116109. doi:10.1016/j.biopha.2023.116109. https://pubmed.ncbi.nlm.nih.gov/38185042/
6. Wu, Z, Shi, J, Song, Y, Gao, P, Wang, Z. . Claudin-7 (CLDN7) is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, invasion and maintains mesenchymal state. In Neoplasma, 65, 349-359. doi:10.4149/neo_2018_170320N200. https://pubmed.ncbi.nlm.nih.gov/29788731/
7. Li, Yifan, Gong, Yanqing, Ning, Xianghui, Li, Xuesong, Zhou, Liqun. 2018. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis. In Journal of experimental & clinical cancer research : CR, 37, 276. doi:10.1186/s13046-018-0924-y. https://pubmed.ncbi.nlm.nih.gov/30428910/
8. West, Junior J, Golloshi, Rosela, Cho, Chae Yun, Fertig, Elana J, Ewald, Andrew J. 2024. Claudin 7 suppresses invasion and metastasis through repression of a smooth muscle actin program. In The Journal of cell biology, 223, . doi:10.1083/jcb.202311002. https://pubmed.ncbi.nlm.nih.gov/39320351/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest